Results 161 to 170 of about 50,881 (191)

Metabotropic glutamate receptor-4 modulates adaptive immunity and restrains neuroinflammation

Nature Network Boston, 2010
F. Fallarino, C. Volpi, F. Fazio, S. Notartomaso, C. Vacca, C. Busceti, S. Bicciato, G. Battaglia, V. Bruno, P. Puccetti, M. Fioretti, F. Nicoletti, U. Grohmann, R. Marco   +13 more
semanticscholar   +1 more source

A Potent and Selective Metabotropic Glutamate Receptor 4 Positive Allosteric Modulator Improves Movement in Rodent Models of Parkinson's Disease

Journal of Pharmacology and Experimental Therapeutics, 2012
E. Le Poul, C. Boléa, Françoise Girard, S. Poli, D. Charvin, B. Campo, Julien Bortoli, Abdhelak Bessif, Bin Luo, A. Koser, Lisa Hodge, K. Smith, A. Dilella, N. Liverton, Fred J Hess, S. Browne, I. Reynolds   +16 more
semanticscholar   +1 more source

Synergy between l-DOPA and a novel positive allosteric modulator of metabotropic glutamate receptor 4: Implications for Parkinson's disease treatment and dyskinesia

Neuropharmacology, 2013
K. Bennouar, M. Uberti, C. Melon, M. Bacolod, H. Jimenez, M. Cajina, L. Goff, D. Doller, P. Gubellini   +8 more
semanticscholar   +1 more source

Electrophysiological and behavioral evidence that modulation of metabotropic glutamate receptor 4 with a new agonist reverses experimental parkinsonism

The FASEB Journal, 2009
C. Beurrier, S. Lopez, Delphine Révy, C. Selvam, C. Goudet, M. Lhérondel, P. Gubellini, L. Kerkerian-Legoff, F. Acher, J. Pin, M. Amalric   +10 more
semanticscholar   +1 more source

Metabotropic glutamate receptor 4 (mGlu4)-positive allosteric modulators for the treatment of Parkinson's disease: historical perspective and review of the patent literature

Expert Opinion on Therapeutic Patents, 2012
C. Lindsley, C. Hopkins
semanticscholar   +1 more source

A review of cancer immunotherapy toxicity

Ca-A Cancer Journal for Clinicians, 2020
Lucy Boyce Kennedy
exaly  

Treatment of muscle‐invasive and advanced bladder cancer in 2020

Ca-A Cancer Journal for Clinicians, 2020
Vaibhav G Patel, William K Oh, Matthew D Galsky   +2 more
exaly  

Recent advances in the drug discovery of metabotropic glutamate receptor 4 (mGluR4) activators for the treatment of CNS and non-CNS disorders

Expert Opinion on Drug Discovery, 2012
Sylvain Celanire, B. Campo
semanticscholar   +1 more source

Metabotropic Glutamate Receptor 4 Expression in Colorectal Carcinoma and Its Prognostic Significance

Clinical Cancer Research, 2005
H. Chang, B. Yoo, Seok-Byung Lim, Seung-Yong Jeong, W. Kim, Jae‐Gahb Park   +5 more
semanticscholar   +1 more source

Breast cancer statistics, 2019

Ca-A Cancer Journal for Clinicians, 2019
Carol E Desantis, Jiemin, Mia M Gaudet
exaly